#BEGIN_DRUGCARD DB04092

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C23H33N5O5

# Chemical_IUPAC_Name:
(2S)-2-{[(2S)-1-{[(2S)-1-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamide

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Apstatin

# HET_ID:
ATN

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C23H33N5O5/c1-14(20(25)30)26-21(31)17-9-5-11-27(17)22(32)18-10-6-12-28(18)23(33)19(29)16(24)13-15-7-3-2-4-8-15/h2-4,7-8,14,16-19,29H,5-6,9-13,24H2,1H3,(H2,25,30)(H,26,31)/t14-,16+,17-,18-,19-/m0/s1

# InChI_Key:
InChIKey=YVUUZAPYLPWFHE-HXFGRODQSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4092

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
459.5386

# Molecular_Weight_Mono:
459.248169191

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1N51

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.41

# Predicted_LogS:
-2.4

# Predicted_Water_Solubility:
1.92e+00 g/l

# Primary_Accession_No:
DB04092

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
447280

# PubChem_Substance_ID:
46504972

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00584

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(N)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:56 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
D00398

# Drug_Target_1_GenBank_ID_Protein:
216529

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
pepP

# Drug_Target_1_Gene_Sequence:
>1326 bp
ATGAGTGAGATATCCCGGCAAGAGTTTCAGCGTCGCCGTCAGGCCCTGGTGGAGCAAATG
CAACCCGGCAGCGCCGCGCTGATTTTTGCTGCACCAGAAGTAACACGTAGCGCCGACAGC
GAATACCCCTATCGTCAGAACAGTGACTTCTGGTACTTCACCGGCTTTAACGAACCGGAA
GCGGTGCTGGTGCTGATTAAAAGCGATGACACTCATAACCACAGCGTTCTGTTTAACCGC
GTTCGCGACCTGACGGCGGAGATCTGGTTTGGCCGTCGCTTAGGCCAGGATGCCGCGCCA
GAGAAACTGGGCGTTGACCGCGCACTGGCATTCAGCGAAATCAATCAGCAACTTTATCAA
CTACTTAACGGCCTGGATGTGGTTTACCATGCCCAGGGCGAATATGCATATGCTGATGTA
ATCGTGAACAGTGCGCTGGAAAAACTGCGTAAAGGTTCGCGGCAAAATCTCACCGCACCG
GCAACGATGATCGACTGGCGTCCTGTTGTTCATGAAATGCGCCTGTTCAAATCGCCAGAA
GAGATTGCCGTACTCCGCCGCGCGGGAGAAATCACCGCCATGGCACATACACGGGCGATG
GAAAAATGCCGTCCGGGAATGTTCGAGTACCATCTGGAAGGCGAAATTCACCACGAATTT
AACCGCCACGGTGCGCGCTATCCGTCCTATAACACCATTGTCGGCAGCGGTGAAAACGGC
TGCATTCTGCACTACACCGAAAACGAGTGTGAAATGCGCGACGGCGACCTGGTGTTGATT
GACGCGGGTTGTGAATACAAAGGTTACGCTGGCGATATTACCCGCACCTTCCCGGTCAAC
GGCAAATTCACCCAGGCCCAGCGTGAAATCTACGACATTGTGCTGGAGTCTCTCGAAACC
AGCCTGCGCCTGTATCGTCCGGGAACTTCCATTCTGGAAGTCACTGGTGAAGTGGTGCGC
ATCATGGTTAGCGGCCTGGTAAAACTCGGCATCCTGAAAGGTGATGTTGATGAACTGATC
GCTCAGAACGCCCATCGTCCTTTCTTTATGCATGGCCTTAGCCACTGGTTAGGACTGGAT
GTCCATGACGTGGGTGTTTATGGTCAGGATCGCTCGCGCATTCTGGAACCGGGCATGGTA
CTGACCGTAGAGCCAGGGCTGTATATTGCGCCGGATGCAGAAGTGCCAGAACAATATCGC
GGTATCGGCATTCGTATTGAAGACGACATTGTGATTACCGAAACCGGTAACGAAAACCTC
ACCGCCAGCGTGGTGAAAAAGCCGGAAGAAATCGAAGCGTTGATGGTTGCTGCGAGAAAG
CAATGA

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
1339425	Nakahigashi K, Miyamoto K, Nishimura K, Inokuchi H: Isolation and characterization of a light-sensitive mutant of Escherichia coli K-12 with a mutation in a gene that is required for the biosynthesis of ubiquinone. J Bacteriol. 1992 Nov;174(22):7352-9.
2659585	Yoshimoto T, Tone H, Honda T, Osatomi K, Kobayashi R, Tsuru D: Sequencing and high expression of aminopeptidase P gene from Escherichia coli HB101. J Biochem (Tokyo). 1989 Mar;105(3):412-6.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9520390	Wilce MC, Bond CS, Dixon NE, Freeman HC, Guss JM, Lilley PE, Wilce JA: Structure and mechanism of a proline-specific aminopeptidase from Escherichia coli. Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3472-7.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2985

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
49816

# Drug_Target_1_Name:
Xaa-Pro aminopeptidase

# Drug_Target_1_Number_of_Residues:
441

# Drug_Target_1_PDB_ID:
1M35

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00557	Peptidase_M24
PF05195	AMP_N

# Drug_Target_1_Protein_Sequence:
>Xaa-Pro aminopeptidase
MSEISRQEFQRRRQALVEQMQPGSAALIFAAPEVTRSADSEYPYRQNSDFWYFTGFNEPE
AVLVLIKSDDTHNHSVLFNRVRDLTAEIWFGRRLGQDAAPEKLGVDRALAFSEINQQLYQ
LLNGLDVVYHAQGEYAYADVIVNSALEKLRKGSRQNLTAPATMIDWRPVVHEMRLFKSPE
EIAVLRRAGEITAMAHTRAMEKCRPGMFEYHLEGEIHHEFNRHGARYPSYNTIVGSGENG
CILHYTENECEMRDGDLVLIDAGCEYKGYAGDITRTFPVNGKFTQAQREIYDIVLESLET
SLRLYRPGTSILEVTGEVVRIMVSGLVKLGILKGDVDELIAQNAHRPFFMHGLSHWLGLD
VHDVGVYGQDRSRILEPGMVLTVEPGLYIAPDAEVPEQYRGIGIRIEDDIVITETGNENL
TASVVKKPEEIEALMVAARKQ

# Drug_Target_1_Reaction:
Release of any N-terminal amino acid, including proline, that is linked to proline, even from a dipeptide or tripeptide COFACTOR Manganese; Cobalt

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Release of any N-terminal amino acid, including proline, that is linked to proline, even from a dipeptide or tripeptide

# Drug_Target_1_SwissProt_ID:
P15034

# Drug_Target_1_SwissProt_Name:
AMPP_ECOLI

# Drug_Target_1_Synonyms:
APP-II
Aminoacylproline aminopeptidase
Aminopeptidase P II
EC 3.4.11.9
X-Pro aminopeptidase

# Drug_Target_1_Theoretical_pI:
5.07

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04092
